NuVasive (NUVA)

Add to Watchlists
Create an Alert
33.83 +0.40  +1.20% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
NUVA Price Chart
View All Events

NUVA Events

Date Type Description
Apr 29 Misc Q1 2014 Nuvasiveâ®, Inc. Earnings Conference Call
Apr 29 Earnings Q1 2014 Nuvasiveâ®, Inc. Earnings Results. Estimate: 0.13.
Mar 03 Misc Q4 2013 Nuvasiveâ®, Inc. Earnings Conference Call
Mar 03 Earnings Q4 2013 NuVasive®, Inc. Earnings Results. Estimate: 0.17.
Nov 14 Misc 2013 Investor Meeting Invite
Oct 29 Misc Q3 2013 Nuvasiveâ®, Inc. Earnings Conference Call
Oct 29 Earnings NuVasive(R) Announces Conference Call and Webcast of Third Quarter 2013 Results. Estimate: 0.13.
Jul 30 Misc Nuvasive(r) Announces Conference Call and Webcast of Second Quarter 2013 Results
Jul 30 Earnings NuVasive(R) Announces Conference Call and Webcast of Second Quarter 2013 Results. Estimate: 0.13.
May 23 Misc AGM Event for Nuvasive Inc
View All Performance Charts

NUVA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NuVasive is up 67.48% over the last year vs S&P 500 Total Return up 22.72%, Cardiovascular Systems up 48.94%, and Baxter International up 6.68%.

Get Quote for

PDF Report for NUVA

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NUVA Pro Report PDF

Portfolio Strategies Featuring NUVA

Did NuVasive make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NUVA Profile

  • Sector: Healthcare
  • Industry: Medical Devices
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Surgical and Medical Instrument Manufacturing
  • NAICS Code: 339112
  • NAICS Industry: Medical Equipment and Supplies Manufacturing
  • NAICS Industry Code: 3391
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 33

NuVasive, Inc. is a medical device company focused on the design, development and marketing of surgical products for the treatment of spine. Its principal product includes a minimally disruptive surgical platform called Maximum Access Surgery as well as a growing offering of biologics, cervical and motion preservation products and it also provides products for the thoracolumbar spine and the cervical spine. The biologic product line includes allograf FormaGraft, a collagen synthetic product used to aid the fusion process, and Osteocel Plus an allograft cellular matrix containing viable mesenchymal stem cells. The Specialized implants product line includes SpheRx and Armadatm pedicle screw systems, CoRoent suite of implants and several fixation systems. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NUVA 33.83 +0.40 +1.20% 1.554B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.